Cost-effectiveness analysis of current treatment of individuals with acute exacerbation of schizophrenia in Bulgaria
Schizophrenia is a serious mental disorder which requires complex treatment and care. Although proof for effective, cost-effective and affordable treatment is available, health economic research is lacking in many low and middle-income countries. The aim of this study was to evaluate the costs and o...
Main Authors: | Desislava Ignatova, Maria Kamusheva, Guenka Petrova, Georgi Onchev |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-01-01
|
Series: | Biotechnology & Biotechnological Equipment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/13102818.2018.1561209 |
Similar Items
-
Pilot Study on the Cost of Some Oncohematology Diseases in Bulgaria
by: Konstantin Tachkov, et al.
Published: (2019-03-01) -
Hospitalization and cost after switching from atypical to typical antipsychotics in schizophrenia patients in Thailand
by: Boonlue T, et al.
Published: (2016-04-01) -
Chronic Hepatitis C-Related Cirrhosis Hospitalization Cost Analysis in Bulgaria
by: Maria Dimitrova, et al.
Published: (2017-08-01) -
New Epidemiological, Clinical and Economic Data for Patients With Acromegaly in Bulgaria
by: Maria Kamusheva, et al.
Published: (2020-04-01) -
Cost of schizophrenia: direct costs and use of resources in the State of São Paulo
by: Leitão Raquel Jales, et al.
Published: (2006-01-01)